Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Leukemia, Myeloid, Acute 32Myelodysplastic Syndromes 28Multiple Myeloma 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Hodgkin Disease 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Lymphoma, Non-Hodgkin 10Lymphoma 10Hematologic Neoplasms 10Neuroblastoma 9Myeloproliferative Disorders 9Anemia, Refractory, with Excess of Blasts 8Lymphoma, Mantle-Cell 7Leukemia, Myelomonocytic, Chronic 7Leukemia 7Neoplasms, Plasma Cell 6Lymphoma, T-Cell 6Leukemia, Biphenotypic, Acute 6Graft vs Host Disease 6Leukemia, Lymphocytic, Chronic, B-Cell 5Burkitt Lymphoma 5Recurrence 4Primary Myelofibrosis 4Melanoma 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Leukemia, Myelomonocytic, Juvenile 4Hematologic Diseases 4Ganglioneuroblastoma 4Anemia, Aplastic 4

Interventions

thymoglobulin 2fludarabine 2Rituximab 2Cyclophosphamide 2luspatercept 1Tacrolimus 1Mycophenolic Acid 1Melphalan 1Levetiracetam 1Dexamethasone 1Busulfan 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
beta-Thalassemia × Melphalan × 1 year × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡